MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

Topic

July 08, 2015

Doctors Without Borders/Médecins Sans Frontières (MSF) says a new combination of drugs created to treat extensively drug-resistant tuberculosis (XDR-TB) is having a significant impact on a group of patients in the midst of a two-year treatment to cure their disease.

In 2013, an MSF team in Grozny noticed that a growing number of patients with multidrug-resistant TB (MDR-TB) were not responding to second-line drugs, and there was no alternative medication available in the country to help them.

March 23, 2015

For two years, companies and researchers have received awards, accolades, and reams of media coverage for introducing two new drugs to tackle TB. Meanwhile, patients are largely stuck facing the same dismal outcomes they have for decades.

March 23, 2015

MDR-TB is deadly and a major public health issue, but for the past 50 years it has largely been ignored. Now, the needs of patients suffering from tuberculosis are finally being addressed.

March 20, 2015

endTB will provide access to new anti-TB drugs for more than 3,000 people and run clinical trials to identify safer and more effective treatments.

March 19, 2015

Doctors Without Borders and research center in Borstel, Germany, publish findings in New England Journal of Medicine.

February 02, 2015

As fighting continues in the Donetsk region of eastern Ukraine, Doctors Without Borders/Médecins Sans Frontières (MSF) is providing medical supplies, including bandages, syringes, antibiotics and stretchers, to hospitals there. Teams also continue the work of treating patients with drug-resistant tuberculosis in the regional penitentiary system, a program MSF began in 2011.

November 19, 2014

Doctors Without Borders/Médecins Sans Frontières (MSF) decided to try using unmanned aerial vehicles to gather sputum tests for patients suspected of having TB in a remote area of Papua New Guinea. The tests were then flown back to the hospital where they were tested in a lab. This could be a new, revolutionary model for diagnostics that MSF repeats in other remote areas where roads and waterways are not feasible for travel.

November 14, 2014

The tuberculosis (TB) prevalence in Papua New Guinea (PNG) is among the highest in the world, prompting Doctors Without Borders/Médecins Sans Frontières (MSF) to launch a response to reach the most-affected communities.

Assessing the Needs

After analyzing where the greatest needs are, MSF decided to focus on the Gulf Province. This region, which includes many remote communities with limited access to health care, is estimated to have very high rates of TB and possibly a worrisome rise in drug-resistant TB.

October 30, 2014

BARCELONA/NEW YORKOutdated policies and practices and critical gaps in care for drug-resistant tuberculosis (DR-TB) are fueling a worldwide public health crisis, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) in a new report, Out of Step, released today at the 45th Union World Conference on Lung Health.

October 28, 2014

As a teenager, Gibson Chijaka was diagnosed with drug-resistant tuberculosis (DR-TB). Cases like Gibson's are attributed to TB’s highly contagious nature and the high rates of HIV in the region. While early detection and prompt treatment of confirmed cases is key to DR-TB prevention, treatment, and control, this form of TB is very difficult to treat compared to drug sensitive TB. It takes a long time and many pills to get cured, but Gibson went through it all.

Pages